Neoadjuvant Endocrine Therapy in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Highly Endocrine Responsive Operable Breast Cancer
Interventions: DRUG: Letrozole 2.5Mg Tablet|DRUG: GnRH analogue
Sponsor: Guangdong Provincial People's Hospital